scispace - formally typeset
Open AccessJournal ArticleDOI

Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activity

J. Hua, +2 more
- 01 Dec 2010 - 
- Vol. 25, Iss: 6, pp 426-432
Reads0
Chats0
TLDR
The activity of one mimetic, mPE, against biofilm cultures of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis is examined, suggesting that mPE can act both as an anti-biofilm agent in an anaerobic environment and as anAnti-inflammatory agent in infected tissues.
Abstract
Whereas periodontal disease is ultimately of bacterial etiology, from multispecies biofilms of gram-negative anaerobic microorganisms, much of the deleterious effects are caused by the resultant epithelial inflammatory response. Hence, development of a treatment that combines anti-biofilm antibiotic activity with anti-inflammatory activity would be of great utility. Antimicrobial peptides (AMPs) such as defensins are naturally occurring peptides that exhibit broad-spectrum activity as well as a variety of immunomodulatory activities. Furthermore, bacteria do not readily develop resistance to these agents. However, clinical studies have suggested that they do not represent optimal candidates for exogenous therapeutic agents. Small-molecule mimetics of these AMPs exhibit similar activities to the parent peptides, in addition to having low toxicity, high stability and low cost. To determine whether AMP mimetics have the potential for treatment of periodontal disease, we examined the activity of one mimetic, mPE, against biofilm cultures of Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis. Metabolic assays as well as culture and biomass measurement assays demonstrated that mPE exhibits potent activity against biofilm cultures of both species. Furthermore, as little as 2 μg ml(-1) mPE was sufficient to inhibit interleukin-1β-induced secretion of interleukin-8 in both gingival epithelial cells and THP-1 cells. This anti-inflammatory activity is associated with a reduction in activation of nuclear factor-κB, suggesting that mPE can act both as an anti-biofilm agent in an anaerobic environment and as an anti-inflammatory agent in infected tissues.

read more

Citations
More filters
Journal ArticleDOI

Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals

TL;DR: These groups of new peptides have creative medical and industrial application potentials to treat antibiotic-resistant bacterial infections and septic shock, to preserve food or to sanitise surfaces both in vitro and in vivo.
Journal ArticleDOI

Antimicrobial Peptides from Fish

TL;DR: Some of the unique properties of fish peptides, including their ability to act even in very high salt concentrations, make them good potential targets for development as therapeutic antimicrobials.
Journal ArticleDOI

Peptidomimetics as a new generation of antimicrobial agents: current progress.

TL;DR: This review will focus on current findings of antimicrobial peptidomimetics, which can mimic the bactericidal mechanism of AMPs, while being stable to enzymatic degradation and displaying potent activity against multidrug-resistant bacteria.
Journal ArticleDOI

Polymeric Systems of Antimicrobial Peptides—Strategies and Potential Applications

TL;DR: This review presents the recent developments on polymeric AMP carriers and their potential applications in the biomedical and pharmaceutical fields.
References
More filters
Journal ArticleDOI

The Contribution of Interleukin-1 and Tumor Necrosis Factor to Periodontal Tissue Destruction

TL;DR: Much of the damage that occurs duringperiodontal tissue destruction may very well represent an overreaction of the host response to periodontal pathogens caused by excessive production of IL-1 and TNF.
Journal ArticleDOI

Inflammation and Bone Loss in Periodontal Disease

TL;DR: It seems that the reduction of inflammation and attenuation of the host's immune reaction to the microbial plaque, eventually leading to a decreases in the ratio of RANKL/OPG and a decrease in associated bone loss, are the actual and desired outcomes of periodontal therapy.
Journal ArticleDOI

Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm

TL;DR: If systemic antimicrobials are indicated in periodontal therapy, they should be adjunctive to mechanical debridement, but there is not enough evidence to support their use withperiodontal surgery.
Journal ArticleDOI

Novel host response therapeutic approaches to treat periodontal diseases.

TL;DR: This review has sought to provide mechanistic overviews and clinical applications on the use of host modulatory therapeutic regimens for periodontal disease management by using gene therapy vectors to provide a longer-term delivery of tumor necrosis factor receptor antagonists at the periodontium.
Journal ArticleDOI

Biofilm Growth and Detachment of Actinobacillus actinomycetemcomitans

TL;DR: These findings suggest that A. actinomycetemcomitans biofilm growth and detachment are discrete processes and that biofilm cell detachment evidently involves the formation of nonaggregated cells inside the biofilm colony that are destined for release from the colony.
Related Papers (5)
Trending Questions (1)
What is the difference between an antibiotic and an anti inflammatory?

Hence, development of a treatment that combines anti-biofilm antibiotic activity with anti-inflammatory activity would be of great utility.